Skip to main content

Table 2 Oncotype DX validation on GSE17705

From: The effects of lymph node status on predicting outcome in ER+ /HER2- tamoxifen treated breast cancer patients using gene signatures

 

HR

p value

CI upper

CI lower

Combined Patients

1.74

5.5E-02

0.99

3.07

LN- Patients

3.58

1.2E-02

1.38

9.27

LN+ Patients

1.16

6.8E-01

0.57

2.34

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us